Psych Trial Halted After Death; Curbing Phone Addiction; Most Worried Racial Group

(MedPage Today) -- The FDA halted patient enrollment in a phase III trial of evenamide in treatment-resistant schizophrenia following the sudden death of a participant, Newron Pharmaceuticals said. Magnetic seizure therapy achieved similar remission...
Source
MedPage Today
Opens original article in a new tab



